Drug
Talabostat
Talabostat: highest development phase Phase 1/2, developed by BioXcel Therapeutics Inc. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- BioXcel Therapeutics Inc
Trials
| Drug | Phase | Indication |
|---|---|---|
| Talabostat NCT03910660 | Phase 1/2 | Prostate Cancer |
Latest
No recent events.
Follow Talabostat on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.